ArticleCureus2025
Unveiling the Unexpected: A Case of Synergistic Drug Reaction to Cannabidiol.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The widespread use of cannabis derived products has raised concerns with regard to their side effect profile, particularly hepatotoxicity. This case centers around a 45-year-old female patient receiving therapeutic cannabis oil, who demonstrated an acute surge in hepatic transaminases after excluding common etiologies, such as paracetamol and recent flucloxacillin, as both are hepatotoxic. A subsequent improvement in hepatic parameters following discontinuation reinforces the potential for an existing association between cannabis oil and liver injury. Furthermore, this case highlights the need for clinicians to recognize cannabinoid products as potential hepatotoxins, especially in patients with unexplained hepatic dysfunction. Given the growing access to such products, rigorous oversight and research have become essential in identifying potential health hazards and ensuring consumer safety.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.